Leser-Trelat Sign.
Bernett CN, Farrell CL, Schmieder GJ.
2024 Feb 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Sign of Leser-Trelat.
Schwartz RA.
J Am Acad Dermatol. 1996 Jul;35(1):88-95. doi: 10.1016/S0190-9622(96)90502-2.
Sign of Leser-Trelat.
Ellis DL, Yates RA.
Clin Dermatol. 1993 Jan-Mar;11(1):141-8. doi: 10.1016/0738-081x(93)90111-o.
The Pseudo-Sign of Leser-Trelat: A Rare Presentation.
Suening BS, Neidenbach PJ.
Cureus. 2023 Feb 18;15(2):e35155. doi: 10.7759/cureus.35155. eCollection 2023 Feb.
Leser-Trelat sign.
Neverman EM, Clary K.
J Am Osteopath Assoc. 2014 Jul;114(7):593. doi: 10.7556/jaoa.2014.119.
The Leser-Trelat Sign in a Patient with Gastric Adenocarcinoma.
Geber A, Hadžavdić A, Ljubojević Hadžavdić S.
Acta Dermatovenerol Croat. 2023 Aug;31(1):51-52.
Leser-Trelat sign on BRAF inhibitors.
Decaestecker C, Levard R, L'Orphelin JM.
Ann Dermatol Venereol. 2025 Jun;152(2):103368. doi: 10.1016/j.annder.2025.103368. Epub 2025 Apr 19.
Leser-Trelat sign.
Ceylan C, Alper S, Kilinç I.
Int J Dermatol. 2002 Oct;41(10):687-8. doi: 10.1046/j.1365-4362.2002.01600.x.
Sign of Leser-Trelat.
Chakradeo K, Narsinghpura K, Ekladious A.
BMJ Case Rep. 2016 Apr 8;2016:bcr2016215316. doi: 10.1136/bcr-2016-215316.
Leser-Trelat Sign as a Marker for Underlying Pancreatic Cancer.
Modi K, Chen R, Abubshait L.
Clin Pract Cases Emerg Med. 2023 Aug;7(3):202-204. doi: 10.5811/cpcem.1248.
